Dendritic cell vaccination in medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-05-01 / Clin. Cancer Res. 2004 May;10(9):2944-53Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-05-01 / Br. J. Haematol. 2004 May;125(3):343-52Selective functional deficit in dendritic cell–T cell interaction is a crucial mechanism in chronic hepatitis B virus infection
/in Chronic Virus Hepatitis, International Publications /von 2004-05-01 / J. Viral Hepat. 2004 May;11(3):217-24Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia
/in International Publications, NSCLC /von 2004-05-01 / Int J Hyperthermia 2004 May;20(3):252-77Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution